Published On: Wed, Oct 19th, 2016

Analyst Review: HealthSouth Corporation (NYSE:HLS)


A number of investment brokers have recently updated their price targets on shares of HealthSouth Corporation (NYSE:HLS).

Most recent broker ratings

06/27/2016 – HealthSouth Corporation was downgraded to “underweight” by analysts at Barclays. They now have a USD 42 price target on the stock.

04/29/2016 – HealthSouth Corporation had its “buy” rating reiterated by analysts at Mizuho. They now have a USD 47 price target on the stock.

02/25/2016 – HealthSouth Corporation had its “positive” rating reiterated by analysts at Susquehanna. They now have a USD 42 price target on the stock.

11/06/2015 – HealthSouth Corporation had its “neutral” rating reiterated by analysts at Wedbush. They now have a USD 45 price target on the stock.

11/02/2015 – HealthSouth Corporation had its “market outperform” rating reiterated by analysts at JMP Securities. They now have a USD 44 price target on the stock.

10/31/2015 – HealthSouth Corporation had its “outperform” rating reiterated by analysts at Raymond James. They now have a USD 42 price target on the stock.

10/29/2015 – HealthSouth Corporation was downgraded to “hold” by analysts at Stifel Nicolaus.

07/31/2015 – HealthSouth Corporation had its “outperform” rating reiterated by analysts at RBC Capital. They now have a USD 51 price target on the stock.

07/07/2015 – HealthSouth Corporation had its “buy” rating reiterated by analysts at SunTrust. They now have a USD 54 price target on the stock.

06/25/2015 – HealthSouth Corporation had its “hold” rating reiterated by analysts at Deutsche Bank. They now have a USD 48 price target on the stock.

06/11/2015 – HealthSouth Corporation had its “neutral” rating reiterated by analysts at UBS. They now have a USD 45 price target on the stock.

05/01/2015 – HealthSouth Corporation was upgraded to “buy” by analysts at Zacks. They now have a USD 54 price target on the stock.

01/20/2015 – HealthSouth Corporation had its “buy” rating reiterated by analysts at Evercore ISI. They now have a USD 47 price target on the stock.

04/28/2014 – HealthSouth Corporation had its “buy” rating reiterated by analysts at CRT Capital. They now have a USD 39 price target on the stock.

10/28/2013 – HealthSouth Corporation was upgraded to “buy” by analysts at TheStreet.

The share price of HealthSouth Corporation (NYSE:HLS) was up +1.00% during the last day of trading, with a day high of 40.63. 864987 shares were traded during the last session.

The stock’s 50 day moving average is 40.63 and its 200 day moving average is 40.08. The stock’s market capitalization is 3.61B. HealthSouth Corporation has a 52-week low of 30.26 and a 52-week high of 43.38.

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice. It is an owner and operator of inpatient rehabilitation hospitals. It provides specialized rehabilitative treatment on both an inpatient and outpatient basis. It offers its home health and hospice services through Encompass Home Health and Hospice business (Encompass). Encompass operates home health and hospice agencies in 25 states, with concentrations in the Southeast, Oklahoma, and Texas. As of December 31, 2016, the Company operated 123 inpatient rehabilitation hospitals. As of December 31, 2016, the Company managed five inpatient rehabilitation units through management contracts.